Warning Letter Close-Outs – August 2021
The US FDA issued three device-related close-out letters in August.
You may also be interested in...
Several additional batches of Magellan’s LeadCare II tests are being recalled as efforts to address the root cause continue.
The US agency issued a letter to providers in the wake of a study that found significantly higher complication rates in women implanted with Boston Scientific’s Watchman device.
Virtual and in-person events are planned for Washington, DC, and Minneapolis, MN, during the trade group gathering.